Scientific Programme

Scientific Programme

At ISPPD-12 we plan to have an informative and exciting programme that highlights the areas of substantial recent progress while also posing the tough questions where progress has been more challenging.

Wherever possible, plenary sessions will take a cross-disciplinary approach to major areas in the field.

Parallel sessions will allow us to explore specific topics that cover areas that include but are not limited to clinical issues, host-immune interactions, genomics, immunology, microbiology, epidemiology and the interface between these areas.

Meet-the-Expert sessions and workshops will provide opportunities for interaction with professionals in smaller-structured settings.

Researchers at all levels will have an opportunity to present their work in interactive poster sessions. Attention will be given to how to exchange knowledge and translate findings into policy that benefit individuals affected by or a risk of pneumococcal diseases worldwide.


  • Addressing the Burden of Pneumococcal Diseases
  • Host-Pathogen Interactions
  • Emerging Vaccination Strategies
  • Diagnosis and Management
  • Application of Genomics to S. Pneumoniae
  • Pneumococcal Disease and Prevention in Adults
  • Robert Austrian Lecture and Awards
  • Pneumonia and Pneumococcal Disease in the time of COVID-19
  • Pneumococcal Disease in High-Risk Populations
  • Current State of Vaccines and Vaccine Trials



  • Genomics in Public Health: When and How to Use Next-Generation Sequencing
  • Disease Trends in Indigenous Populations in North America
  • Immune Response to Pneumococci and Non-Pneumococci Expressing “Pneumococcal” Capsules
  • Cutting Edge and Conventional Methods for Measuring Pneumococcal Carriage
  • Antimicrobial Resistance
  • What’s the Latest With Serotype Replacement?
  • The Microbiome and Relevance to Pneumococci Disease
  • Basic Science: Lessons from Animal Models
  • Results from the Child Health and Mortality Preventions Surveillance (CHAMPS) Network: What Really Causes Pneumonia Deaths?



  • Disease Burden in Adults and High-risk Groups
  • Immunology, Pathogenesis, and Host-pathogen Interactions
  • Advances in Microbiology
  • Innovations for Pneumonia Prevention and Care in Resource Limited Settings
  • Vaccine Impact
  • Diagnosis and Treatment of Pneumococcal Disease
  • Pneumococcal Disease Control: From Policy to Practice
  • Genome Sequencing, Molecular Epidemiology and Emerging Technologies
  • Disease Burden in Infants and Children
  • Microbiology, the Microbiome, and Pathogen Interactions
  • New Vaccine Products and Vaccination Strategies
  • Mathematical Modeling and Economics